January 30, 2020
Rose
"Hospitals and patients are still getting killed by new million-dollar drugs that won't see any competition for decades," said Dan Kistner, group senior vice president of pharmacy solutions for Vizient. In other pharmaceutical news: Roche posts its growth report, Novartis' gene therapy for infants continues to perform well, CVS figures out a way to help with diabetes medication costs, and scientists dig into the phenomenon of biotech's "missing girls."
from Kaiser Health News https://ift.tt/315MD6A
January 30, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: NYC To Pay Nurses Settlement After Excluding Them From ‘Physically Taxing’ Job Category; Boston Becomes Hot Spot For Tech Geared Toward Aging- Parsing Policy: Trump’s Set On Destorying The ACA Even Though It’s Helped Tens Of Millions Of Americans; Work Requirements Won’t Work
- Viewpoints: Spare End-Of-Life Costs When Seeking Health Care Savings; Why It’s OK For A Doctor To Join A Protest At The Border
- More Marijuana Legislation Focusing On Making Changes To Criminal Justice System, Helping Those Harmed By War On Drugs
- Longer Looks: Celebrities And Opioids; America’s Abortion Capital; And Guideline.gov
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment